Glycosylation Pathways as Drug Targets for Cancer: Glycosidase Inhibitors
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
6
Page:
1043-1052
Author(s):
Sandrine Gerber-Lemaire and Lucienne Juillerat-Jeanneret
STAT3: A Molecular Target for Cancer Whose Time Has Come
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
239-253
Author(s):
Beverly E. Barton
n-3 Polyunsaturated Fatty Acids as Signal Transduction Modulators and Therapeutical Agents in Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
255-271
Author(s):
Gabriella Calviello, Simona Serini and Paola Palozza
Emerging Role of Stromal Fibroblasts in Epithelial Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
273-283
Author(s):
Maria Rita Rippo, Antonio Procopio and Alfonso Catalano
Targeting Phospholipase D-mediated Survival Signals in Cancer
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
295-303
Author(s):
David A. Foster
Carotenoids as Modulators of Intracellular Signaling Pathways
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
325-335
Author(s):
Paola Palozza, Simona Serini and Gabriella Calviello
Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
337-351
Author(s):
Edith Pfitzner, Frank Nonnenmacher and Daniela Baus
Drug Targets to Pro-Angiogenetic Factors with Special Reference to Primary Peritoneal Mesothelioma
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
6
Page:
271-277
Author(s):
Girolamo Ranieri, Eustachio Ruggieri, Gaetano Falco, Nicola Zizzo, Eliseo Mattioli, Alfredo Francesco Zito, Rosa Patruno and Giampietro Gasparini
The ‘Arimidex’, Tamoxifen, Alone or in Combination (ATAC) Trial: A Step Forward in the Treatment of Early Breast Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
207-215
Author(s):
Anthony Howell
The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
237-249
Author(s):
Jean Marc Nabholtz and Joseph Gligorov